Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents.

MLA

Kotb, Anas Ramadan, et al. “Design, Synthesis, and Biological Evaluation of Novel Bioactive Thalidomide Analogs as Anticancer Immunomodulatory Agents.” RSC Advances, vol. 12, no. 52, Nov. 2022, pp. 33525–39. EBSCOhost, https://doi.org/10.1039/d2ra06188k.

APA

Kotb, A. R., Bakhotmah, D. A., Abdallah, A. E., Elkady, H., Taghour, M. S., Eissa, I. H., & El-Zahabi, M. A. (2022). Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents. RSC Advances, 12(52), 33525–33539. https://doi.org/10.1039/d2ra06188k

Chicago

Kotb, Anas Ramadan, Dina A Bakhotmah, Abdallah E Abdallah, Hazem Elkady, Mohammed S Taghour, Ibrahim H Eissa, and Mohamed Ayman El-Zahabi. 2022. “Design, Synthesis, and Biological Evaluation of Novel Bioactive Thalidomide Analogs as Anticancer Immunomodulatory Agents.” RSC Advances 12 (52): 33525–39. doi:10.1039/d2ra06188k.